2018 Year End LetterDecember 18, 2018
A Visit to Hospital de Niños – Kurt FlorianFebruary 20, 2019
The ROW Foundation has donated enough of the antiepileptic drug (AED) Roweepra to cover 63,000 months of treatment. We can’t know for sure how many children and adults in underserved parts of the world are benefiting from our medication grants, but the number is growing rapidly. And once a patient starts on Roweepra we are committed to maintaining their supply of this vital medication. As our founding president, Dr. Paul Regan explains, “When we enter into a partnership with healthcare providers, it’s a long-term commitment because epilepsy is a lifetime struggle. We don’t want to start people on helpful treatment that can’t be sustained. And as the need grows we’ll be able to send more medication, thanks to the generosity of OWP.”
American Epilepsy Society Annual Meeting
Nov. 30-Dec. 4, 2018
Ken Koskela at ROW booth
AES is the largest gathering in the world for epilepsy professionals in academia, clinical practice, industry and advocacy. ROW and OWP had booths again this year. We met with a number of potential partners for future ROW projects. Especially exciting was a connection with a doctor looking for AEDs for a large refugee camp with a severe shortage of medications. Stay tuned for details!
Dr. Emilio Perucca will shift from our advisory counsel to our board of directors. Dr. Perucca is Professor of Pharmacology at the University of Pavia (Italy) Medical School and Director of the Clinical Trial Centre at Mondino Foundation’s National Institute of Neurology in Pavia. Emilio has served many roles with the International League Against Epilepsy (ILAE), including four years as President.
Dr. Serge Pierre-Louis has joined our advisory council. He attended medical school at the State University of Haiti. He trained in Internal Medicine and Neurology in Cleveland, then in epilepsy in Chicago. He is Associate- Professor in Neurology at Rush University Medical Center and Director of the Epilepsy Clinic & the Clinical Neurophysiology Lab at John H. Stroger, Jr. Hospital in Chicago.
OWP Pharmaceuticals covers our operating costs and core programs but there’s so much more to be done! We are always looking for new partners who share our vision to bring hope to those suffering with epilepsy and associated psychiatric disorders. Visit our website to learn more, https://rowpharma.org.